Purchase Order W81K0025PA232
- Not listed
- The Defense Health Agency awarded a definitive firm fixed-price contract valued at $458,582.50 to Southeast Apothecary Opelika, Inc., a woman-owned small disadvantaged business, on November 15, 2020. The contract calls for the delivery of unit dose radiopharmaceuticals in individually shielded plastic syringes to Martin Army Community Hospital at Fort Moore, Georgia. The contractor must provide daily deliveries to the hospital's Nuclear Medicine Hot Lab, maintain capability for emergency...
- The Department of the Army Medical Command awarded a $442,915.50 Definitive Contract with a Firm Fixed Price to Southeast Apothecary Opelika, Inc., a Self Certified Small Disadvantaged Business, For Profit Organization, Woman Owned Small Business, Woman Owned Business, and Subchapter S Corporation, for Unit Dose Radiopharmaceuticals. The parent company is Southeast Apothecary, Inc., which is also a Self Certified Small Disadvantaged Business, For Profit Organization, Woman Owned Business, and...
- The Defense Health Agency (DHA) awarded a $137,293.52 firm fixed-price purchase order to Petnet Solutions, Inc. on October 1, 2023, for the supply of radiological isotopes including Tauvid, Amyvid, and Cerianna. The contract is set to conclude on September 30, 2026, with performance taking place in Portsmouth, Virginia. This award was issued without set-aside designation, reflecting Petnet Solutions' competitive standing in the radiopharmaceutical market. Petnet Solutions, a Siemens subsidiary...
- This is a $164,019.38 firm fixed-price purchase order contract awarded to Trillamed LLC, a service-disabled veteran-owned small business (SDVOSB), by the Defense Health Agency. The contract is for the delivery of FDA-approved F-18 Fludeoxyglucose (FDG) unit dose radiopharmaceuticals for PET imaging to the Dwight David Eisenhower Army Medical Center Department of Radiology at Fort Gordon, Georgia. The contract has a period of performance through July 5, 2026. This award appears to be part of a...
- The Defense Health Agency awarded a $43,658.48 firm fixed price Blanket Purchase Agreement (BPA) call to Sofie CO., doing business as IBA Molecular, for radiopharmaceuticals. The contract, awarded on May 27, 2025, with an ultimate completion date of September 30, 2025, represents a task order under an existing BPA vehicle and carries no set-aside designation. Performance will be conducted in Sterling, Virginia, where Sofie CO. is headquartered. Sofie CO., a for-profit subsidiary of Sofie...
- This contract was awarded by the Defense Health Agency (DHA) to Pharmalucence, Inc., a specialty pharmaceutical manufacturer, to provide radiopharmaceuticals and supplies. The contract is a firm fixed price blanket purchase agreement (BPA) call with a potential value of $25,000.00 and a completion date of September 30, 2023. The products will be delivered to facilities in El Paso, Texas to support nuclear medicine diagnostic services for the Military Health System's 9.5 million beneficiaries....
- The Defense Health Agency awarded a $427,002.42 firm fixed-price purchase order to RLS (USA) Inc. for radiopharmaceuticals, effective October 1, 2025, with performance completion targeted for September 30, 2029. The contract is to be performed at Fort Cavazos, Texas, and includes no set-aside designation. RLS (USA) Inc., a foreign-owned radiopharmacy company operating 31 facilities across 18 states, specializes in supplying time-sensitive radiopharmaceutical products to federal healthcare...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc., a specialty pharmaceutical manufacturer. The $17,447 contract is for the delivery of molecular imaging products for nuclear medicine, specifically Pharmalucence's SC05 Sulfur Colloid radiopharmaceutical kits. The contract has no set-aside designation, indicating open competition. Pharmalucence, Inc. is a for-profit, Subchapter S Corporation...
- This federal contract award is for the provision of radiopharmaceuticals to the Dublin VA Medical Center and Carl Vinson VA Medical Center in Georgia. The contract, valued at $384,837.44, was awarded on May 1, 2024 to Palmetto Isotopes, LLC, a woman-owned small business located in Ridgeland, South Carolina. The contract is a firm-fixed-price purchase order with a completion date of April 30, 2029. The contract is set aside for total small business, with the anticipated NAICS code being 325412...
- This is a $548,114.25 firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 6 to Numed Diagnostics LLC, a woman-owned small business. The contract is for the provision of radiopharmaceuticals and associated supplies to the Charles George VA Medical Center in Asheville, North Carolina. The award is a total small business set-aside under NAICS code 325412 for pharmaceutical preparation...
The Defense Health Agency awarded a $557.7K firm fixed-price purchase order to Southeast Apothecary, Inc. for the supply of unit dose radiopharmaceuticals to Martin Army Community Hospital at Fort Moore, Georgia. The contract, set aside for small businesses, runs from October 1, 2025, through September 30, 2026, with four twelve-month option periods extending through September 30, 2030, bringing the potential total value to approximately $2.2M. Southeast Apothecary is a woman-owned small disadvantaged business specializing in radiopharmaceutical supply and delivery to federal healthcare facilities, demonstrating established expertise in meeting the regulatory requirements associated with handling and transporting radioactive medical materials. This award reflects the Defense Health Agency's commitment to securing specialized pharmaceutical services for military treatment facilities through small business contracting vehicles. Southeast Apothecary's prior experience delivering radiopharmaceuticals to federal healthcare systems, including the Department of Veterans Affairs and other Defense Health Agency facilities, positions the contractor to fulfill the medical imaging and therapeutic needs of Fort Moore's patient population. The firm fixed-price structure provides cost certainty for the government while the multi-year option periods afford flexibility to extend the relationship based on performance.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/15/25 |